A small 2021 study found that people living with obesity reduced their body fat using the supplement for 12 weeks, but only 60 individuals were involved in the study, and it did not involve a patch
the numbers look larger but the design cannot support a head-to-head claim.9 In paediatric type 1 there are no Phase 3 trials at all, a gap ISPAD 2024 flags explicitly.6 Longer, larger AID-era trials with hard outcomes, paediatric data, and head-to-head tirzepatide RCTs would all strengthen it
However, because DOACs have predictable pharmacokinetics and do not require routine monitoring, the clinical risk is lower
Though Ozempic and Wegovy have fast become household names, many are still unaware that these drugs have their origins in university research
GLP-1 injections use a very small needle just under the skin, and your care team walks you through it